JP2014504598A5 - - Google Patents

Download PDF

Info

Publication number
JP2014504598A5
JP2014504598A5 JP2013549933A JP2013549933A JP2014504598A5 JP 2014504598 A5 JP2014504598 A5 JP 2014504598A5 JP 2013549933 A JP2013549933 A JP 2013549933A JP 2013549933 A JP2013549933 A JP 2013549933A JP 2014504598 A5 JP2014504598 A5 JP 2014504598A5
Authority
JP
Japan
Prior art keywords
group
cys
disease
peptide
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013549933A
Other languages
English (en)
Japanese (ja)
Other versions
JP5943433B2 (ja
JP2014504598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2012/000032 external-priority patent/WO2012098546A2/en
Publication of JP2014504598A publication Critical patent/JP2014504598A/ja
Publication of JP2014504598A5 publication Critical patent/JP2014504598A5/ja
Application granted granted Critical
Publication of JP5943433B2 publication Critical patent/JP5943433B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013549933A 2011-01-20 2012-01-19 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用 Expired - Fee Related JP5943433B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161434454P 2011-01-20 2011-01-20
US61/434,454 2011-01-20
US201161469138P 2011-03-30 2011-03-30
US61/469,138 2011-03-30
PCT/IL2012/000032 WO2012098546A2 (en) 2011-01-20 2012-01-19 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2014504598A JP2014504598A (ja) 2014-02-24
JP2014504598A5 true JP2014504598A5 (https=) 2015-03-05
JP5943433B2 JP5943433B2 (ja) 2016-07-05

Family

ID=45755445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013549933A Expired - Fee Related JP5943433B2 (ja) 2011-01-20 2012-01-19 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用

Country Status (8)

Country Link
US (3) US8802635B2 (https=)
EP (2) EP2665742B1 (https=)
JP (1) JP5943433B2 (https=)
CN (2) CN103415532B (https=)
AU (1) AU2012208283B2 (https=)
CA (1) CA2825273A1 (https=)
IN (1) IN2013MN01582A (https=)
WO (1) WO2012098546A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104717970A (zh) 2012-07-23 2015-06-17 万德-生物技术及制药有限公司 提高谷胱甘肽的组合物及其用途
WO2014016837A1 (en) * 2012-07-25 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions and methods for increasing carnitine level in muscle tissues
CN103467569B (zh) * 2013-08-10 2015-05-20 李�昊 一种抗菌止痒消炎消肿去疤痕的短肽及其应用
EP3674297A1 (en) 2013-11-08 2020-07-01 Promentis Pharmaceuticals, Inc. Substituted n-acetyl-l-cysteine derivatives and related compounds
CA2932408A1 (en) * 2013-12-02 2015-06-11 Stealth Biotherapeutics Corp Compositions and methods for treating vitiligo
WO2015118546A1 (en) * 2014-02-10 2015-08-13 Oneday - Biotech And Pharma Ltd. Mucolytic compositions and uses thereof
US9464111B2 (en) 2014-06-26 2016-10-11 L'oreal Short peptides and a method of use as an antioxidant
BR112017002192A2 (pt) * 2014-08-05 2018-01-16 Amantin Experts composições protetoras para a pele
JP6533723B2 (ja) * 2015-09-11 2019-06-19 キユーピー株式会社 抗酸化剤
CN105254714B (zh) * 2015-10-16 2019-09-10 中国农业大学 一种源自酪蛋白的抗氧化肽及应用
CN106432014B (zh) * 2016-09-05 2019-08-16 中国医学科学院放射医学研究所 胺基硫醇类化合物及其制备方法和其在辐射防护中的应用
CN106749525B (zh) * 2016-12-07 2020-01-07 南京财经大学 一种小肽及其应用
KR101943081B1 (ko) * 2017-08-31 2019-01-29 (주)케어젠 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
JP7100390B2 (ja) * 2017-09-18 2022-07-13 エニジェン カンパニー．，リミテッド． 活性物質－ヘキサペプチド複合体、及びこれを含む化粧料組成物
CN108484738B (zh) * 2018-03-28 2022-03-15 中国人民解放军军事科学院军事医学研究院 辐抗肽突变蛋白及其制备与纯化方法
WO2021230393A1 (ko) * 2020-05-12 2021-11-18 주식회사 카인사이언스 염증성 피부질환 치료용 펩타이드 및 이의 용도
CN112608966B (zh) * 2020-12-31 2023-05-23 华南理工大学 一种超声辅助矿物质螯合杏仁肽及其制备方法和应用
CN114041603A (zh) * 2021-11-09 2022-02-15 中国农业大学 肽-锌螯合物在抗过敏产品中的应用
EP4554553A1 (en) * 2022-07-13 2025-05-21 L'oreal Modified peptides, composition, method for inhibiting contraction of muscle cells, method for improving the skin and use of a modified peptide
CN115920014A (zh) * 2022-12-08 2023-04-07 酵之美生物科技(绍兴)有限责任公司 硫氧还蛋白的模拟肽的一种治疗炎症性肠病的用途

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
AU3643497A (en) * 1996-06-28 1998-01-21 National Jewish Center For Immunology And Respiratory Medicine Use of thioredoxin-like molecules for induction of mnsod to treat oxidative damage
US5928926A (en) * 1996-07-01 1999-07-27 Research Development Foundation Isolation and cloning of the human ARSA-I gene and uses thereof
US5874468A (en) 1996-12-26 1999-02-23 Yissum Brain targeted low molecular weight hydrophobic antioxidant compounds
US6369106B1 (en) 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US5889055A (en) 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
US6627746B1 (en) * 1998-04-17 2003-09-30 Exelixis, Inc. Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
WO1999062927A1 (en) 1998-06-05 1999-12-09 Human Genome Sciences, Inc. Connective tissue growth factor-4
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
GB0108491D0 (en) * 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
AU2003234146A1 (en) 2002-04-22 2003-11-03 Experimental And Applied Sciences, Inc. Food supplements containing 4-hydroxyisoleucine and creatine
CA2498581C (en) 2002-09-10 2019-03-19 National Jewish Medical And Research Center Thioredoxin composition and uses thereof for liquefaction of mucus or sputum
US7361747B2 (en) * 2003-05-22 2008-04-22 The University Of Hong Kong Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus
CA2529863A1 (en) * 2003-06-17 2004-12-23 Vib Vzw Peptide combos and their uses
ITRM20040066A1 (it) * 2004-02-09 2004-05-09 Consiglio Nazionale Ricerche Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1.
CA2514687A1 (en) 2004-06-09 2005-12-09 William Feinstein Advenced vitamin c-based composition with enhanced biotransformation and utilization of protein and l-carnitine for nutritional supplementation or the like
RU2008102646A (ru) * 2005-06-24 2009-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) Применение цитозиндезаминаз для уменьшения переноса ретроэлементов от свиней человеку
WO2007144979A1 (ja) * 2006-06-12 2007-12-21 Vexon, Inc. ペプチド誘導体
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US20090285912A1 (en) 2008-05-16 2009-11-19 Ramiro Rodriquez Food Supplement and Method for Enhancing Athletic Performance
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
CN104717970A (zh) 2012-07-23 2015-06-17 万德-生物技术及制药有限公司 提高谷胱甘肽的组合物及其用途
WO2014016837A1 (en) 2012-07-25 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions and methods for increasing carnitine level in muscle tissues

Similar Documents

Publication Publication Date Title
JP2014504598A5 (https=)
CY1123749T1 (el) Μεθοδοι μειωσης του κινδυνου καρδιαγγειακου γεγονοτος σε ενα υποκειμενο επι θεραπειας στατινης χρησιμοποιωντας αιθυλ εστερα εικοσαπενταενοϊκου οξεος
ES2613606T3 (es) Uso de derivados de ácidos grasos polinsaturados como medicamentos
JP7025212B2 (ja) 炎症性、変性及び神経変性疾患の治療のための化合物、組成物及び方法
CY1122628T1 (el) Χρηση αιθυλεστερα εικοσαπενταενοϊκου οξεος για θεραπεια υπερτριγλυκεριδαιμιας
HK1204272A1 (en) Methods of treating pediatric metabolic syndrome
HRP20200394T1 (hr) Smjesa masnih kiselina (gmk, grupa masnih kiselina) za primjenu u liječenju inflamatornih patologija
JP2013515742A5 (https=)
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
MX355035B (es) Composición de uridina y citidina para uso en la prevención o tratamiento de neurotrauma.
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
NZ709083A (en) Eicosapentaenoic acid (epa) formulations
WO2011015634A3 (en) Controlled release formulations of lipocalin muteins
HRP20160203T1 (hr) Pripravci koji sadrže 15-hepe i postupci njihove upotrebe
JP2019513752A5 (https=)
MY145985A (en) Dha esters and use thereof in treatment and prevention of cardiovascular disease
JP2017523230A5 (https=)
JP2016501248A5 (https=)
JP2019052168A (ja) オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ
JP2006503031A5 (https=)
WO2014193652A3 (en) Novel n-3 immunoresolvents: structures and actions
JP2010522146A5 (https=)
WO2011143271A3 (en) Therapeutic liposomes and methods for producing and using the same
JP2004520343A5 (https=)
FI3426237T3 (fi) Menetelmä aivojen atrofian hoitamiseksi